24 April 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan University
Fareedi Mukram Ali
1ABEFG*, Ghassan M. Al-Iryani 23ABCEF, Khurshid A. Mattoo 4BCDEF, Mohammed Mousa H. Bakri 1ADEF, Ahmed Shaher Alqahtani 1ABEF, Somaih Abdullah Alasiri 5CDEF, Atheer Othman Hakami 6ADEF, Farheen Ustad 7CDEG, Hanan G. Shanab 7ACDEG, Khalid A. Al-Hamad 7ACDEG, Turki F. Almutairi 7ACDEG, Imran Khalid8CDEF
DOI: 10.12659/MSM.943884
Med Sci Monit 2024; 30:e943884
Table 1 Prevalence rates (number and percentage) of healthy patients and patients with medical comorbidities observed during the 1-year time period.
| Parameter | Age | Prevalence | |||
|---|---|---|---|---|---|
| Male (n=300)M±SD | Female (n=340) M+SD | Male (%) | Female (%) | Combined prevalenceN=640 (%) | |
| Total patients | 39.84±7.66 | 41.32±8.14 | 300 (46.87) | 340 (53.12) | 640 |
| Healthy patients | 38.19±8.45 | 40.28±9.67 | 203 (67.67) | 261 (76.76) | 464 (72.5) |
| Comorbid patients | 43.09±7.87 | 45.74±8.79 | 97 (32.33) | 79 (23.23) | 176 (27.5) |
| Endocrine | 55.5±8.75 | 52.01±10.28 | 25 (8.33) | 20 (5.89) | 45 (7.03) |
| Cardiovascular | 57.5±8.55 | 59.5±10.71 | 26 (8.67) | 17 (5.00) | 43 (6.71) |
| Respiratory | 38.5±7.53 | 35.25±8.75 | 15 (5.00) | 14 (4.12) | 29 (4.53) |
| Hematological | 40.17±12.67 | 45.25±15.55 | 13 (4.33) | 9 (2.66) | 22 (3.43) |
| Gastrointestinal | 45.22±10.43 | 44.78±11.23 | 5 (1.67) | 4 (1.18) | 9 (1.40) |
| Neurological | 32.5±15.07 | 43.5±6.59 | 2 (0.67) | 4 (1.18) | 6 (0.93) |
| Drug allergy | 33.82±10.34 | 32.98±9.12 | 3 (1.00) | 2 (0.58) | 5 (0.79) |
| Genitourinary | 44.14±7.25 | 43.19±6.65 | 2 (0.67) | 2 (0.58) | 4 (0.62) |
| Dermatological | 35.5±7.58 | 30.5±6.88 | 2 (0.67) | 2 (0.58) | 4 (0.62) |
| Hepatobiliary | 44.88±9.78 | 46.56±8.79 | 1 (0.33) | 1 (0.29) | 2 (0.31) |
| Miscellaneous* | 45.35±11.78 | 47.67±9.88 | 3 (1.00) | 4 (1.17) | 7 (1.08) |
| M – mean; SD – standard deviation. * Includes cancer, psychological disorder, immunodeficiencies, and nonspecific infections and diseases. | |||||